                               SEQUENCE LISTING

<110> EXPRESSION DRUG DESIGNS, LLC
 
<120> SPHINGOSINE 1-PHOSPHATE ANTAGONISM

<130> 030163.00004

<140> PCT/US2009/045274
<141> 2009-05-27

<150> 12/391,664
<151> 2009-02-24

<160> 2     

<170> PatentIn version 3.5

<210> 1
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide

<400> 1
Lys Lys Thr Phe Ser Leu Ser Pro Thr Val Trp Phe Leu Arg Glu Gly 
1               5                   10                  15      


<210> 2
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic oligonucleotide


<220>
<221> modified_base
<222> (13)..(18)
<223> May or may not be present

<400> 2
tttttttttt tttttttt                                                     18


